Iafigliola Sergio Giamas, Guimarães Thais Moura, D'Almeida Vânia, Poyares Dalva, Dal-Fabbro Cibele, Tufik Sergio, Moreira Gustavo A
Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
Departamento de Psicobiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
Sleep Sci. 2024 May 15;17(4):e466-e469. doi: 10.1055/s-0044-1780502. eCollection 2024 Dec.
Myasthenia gravis (MG) is a chronic autoimmune disease characterized by progressive weakness and skeletal muscle fatigue due to the destruction of acetylcholine receptors, causing an abnormality in the synaptic junction between innervation and muscle fibers. The treatment of patients with MG and obstructive sleep apnea (OSA) is positive pressure in the airway; however, the lack of adherence to the protocol can lead to increased morbidity. A known alternative treatment for OSA is the mandibular advancement device (MAD). The objective of the present report is to describe an emblematic case of a 50-year-old male patient with MG with sleep complaints and documented OSA, and his response to different treatment approaches.
重症肌无力(MG)是一种慢性自身免疫性疾病,其特征是由于乙酰胆碱受体的破坏导致进行性肌无力和骨骼肌疲劳,从而引起神经支配与肌纤维之间突触连接异常。重症肌无力患者和阻塞性睡眠呼吸暂停(OSA)患者的治疗方法是气道正压通气;然而,不遵守该方案会导致发病率增加。一种已知的阻塞性睡眠呼吸暂停替代治疗方法是下颌前移装置(MAD)。本报告的目的是描述一名50岁男性重症肌无力患者的典型病例,该患者有睡眠相关主诉且确诊为阻塞性睡眠呼吸暂停,以及他对不同治疗方法的反应。